Management of neurogenic bladder dysfunction secondary to myelomeningocele
- PMID: 2079080
- DOI: 10.1007/BF01959484
Management of neurogenic bladder dysfunction secondary to myelomeningocele
Abstract
We investigated 55 children, aged from 24 months to 14 years with neurogenic bladder dysfunction secondary to myelomeningocele, by serial urodynamic. They were serially evaluation over 2-5 years. Management consisted of drug therapy together with intermittent vesical catheterization in different combinations on the basis of initial urodynamic assessment. In 5 children with a hypotonic sphincter, it was necessary to implant an artificial sphincter. With this regimen control or frank improvement of micturition was achieved in 53 patients, urodynamic function became normal or improved in 54, and recurrent urinary tract infections persisted only in 5 patients. In the light of these results, we believe that treatment of the neurogenic bladder secondary to myelomeningocele should be determined by initial urodynamic evaluation.
Similar articles
-
[Treatment of neurogenic bladder secondary to myelomeningocele based on the urodynamic status with intermittent catheterization associated with drugs. Preliminary results].An Esp Pediatr. 1987 Feb;26(2):103-6. An Esp Pediatr. 1987. PMID: 3565950 Spanish.
-
The role of adjunctive drug therapy for intermittent catheterization and self-catheterization in children with vesical dysfunction.J Urol. 1978 Apr;119(4):551-4. doi: 10.1016/s0022-5347(17)57545-x. J Urol. 1978. PMID: 650768
-
[Combination of drugs and clean intermittent catheterization in the treatment of neurogenic bladder. Effect on continence].An Esp Pediatr. 1987 Nov;27(5):343-6. An Esp Pediatr. 1987. PMID: 3439656 Spanish.
-
[Neurogenic bladder caused by meningomyelocele in childhood: urodynamic pattern and treatment regimens].Arch Esp Urol. 1990 May;43(4):371-4. Arch Esp Urol. 1990. PMID: 2200353 Review. Spanish.
-
Bladder-sphincter dysfunction in myelomeningocele.Eur J Pediatr. 2001 Jul;160(7):414-20. doi: 10.1007/s004310100741. Eur J Pediatr. 2001. PMID: 11475578 Review.